木瓜直播

Abbott issued an on a few lots of FreeStyle Libre 3 continuous glucose monitors.

Researchers found no link between DPP-4 inhibitors, SGLT2 inhibitors, or GLP-1 receptor agonists and the . (Journal of Diabetes and Its Complications)

The Endocrine Society said with the Association of Program Directors in Endocrinology, Diabetes, and Metabolism.

In the wake of Novo Nordisk's plan to from the market by the end of 2024, some patients have described events of hypoglycemia and rapid glucose fluctuations with other long-acting insulins Novo recommended as safe alternatives. (Reuters)

A work group issued of transgender and gender-diverse individuals. (Anaesthesia)

Fractyl Health announced that the FDA granted a for weight-loss maintenance after discontinuation of a GLP-1 receptor agonist. An outpatient endoscopic procedure, Revita works by resurfacing the mucosal lining of the duodenum.

Following positive results from the phase II VENTURE study, to move its investigational subcutaneous GLP-1/GIP obesity drug into a phase III trial.

When ChatGPT was asked to plans for type 2 diabetes and metabolic syndrome, dietitians identified a number of gaps in the output generated. (European Journal of Clinical Nutrition)

About 14% of all U.S. conventional are per- and polyfluoroalkyl substances, a class of endocrine-disrupting chemicals. (Environmental Health Perspectives)

Higher -- a gut-microbiota-related metabolite -- were linked with elevated coronary heart disease risk, especially among women who ate more animal foods and fewer plant-based foods. (Journal of Clinical Endocrinology & Metabolism)

In a 12-month phase II study, beta-cell function was 49% higher in adolescents with treated with the monoclonal antibody ustekinumab (Stelara) versus placebo. (Nature Medicine)

Comment